Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  

| More

City Union Bank - Q4FY22 Result Update - Asset quality on the mend - BUY

Posted On: 2022-06-16 17:43:14 (Time Zone: IST)

Mr. Gaurav Jani - Research Analyst at Prabhudas Lilladher.

Quick Pointers:

- GNPA/NNPA decline led by better recoveries; OTR/ECLGS performing well.

- PAT beat led by lower opex and higher AUCA recoveries; NIM weaker.

City Union Bank (CUBK) saw a good quarter as asset quality was best ever in recent times. GNPA/NNPA declined sharply QoQ (~50bps each) on the back of stronger NPA recoveries while the OTR and ECLGS pools are performing well. Combined expsoure to ECLGS and OTR at ~Rs49bn is stable QoQ although SMA-1/2 within ECLGS and non-paying OTR pool have reduced as superior repayment ability of customers have sustained. PAT at Rs2.1bn was ahead led by lower opex and higher AUCA recoveries. Credit for FY23 may grow by 10-15% with incremental flow being towards non-gold. NIM was weaker owing to higher liquidity although we do see NIM levers in place. With an expected RoE of 13% in FY24E, CUBK is attractively valued although we lower multiple from 1.8x to 1.7x as we trim FY23/24 earnings by average 5% led by lower margins. Retain BUY but revise TP from Rs180 to Rs170.

Lower opex and higher AUCA recoveries drove PAT beat: NII was in-line at Rs5.01bn even as loan growth was a tad better at 11.6%. NIM was a miss at 3.8% (PLe3.9%) due to lower yields owing to increased liquidity. Other income was a tad better at Rs2.0bn (PLe Rs1.9bn) with AUCA recoveries being higher at Rs739mn (last quarter Rs469mn). Fees at Rs788mn was largely in-line. Opex was lower at Rs2.6bn (PLe Rs3.1bn) due to both employee and other opex. Driven by lower opex and better other income PPoP surprised positively at Rs4.4bn (PLe Rs3.8bn). Provisions were higher at Rs1.7bn (PLe Rs1.4bn) which includes NPA provisions of Rs1.15bn. GNPA/NNPA improved QoQ by ~50bps each to 4.7%/3.0% owing to higher recoveries while PCR improved QoQ from 35% to 38%. PAT was ahead at Rs2.1bn (PLe Rs1.9bn).

Asset quality showed all-round improvement: Slippages were in-line at Rs2.2bn and declined QoQ while GNPA/NNPA reduced as recoveries were higher and improved to Rs2.1bn (PLe Rs1.85bn). However, provisions were more as CUBK provided additional Rs450mn on Spicejet (YTD provision Rs850mn); its total exposure is Rs1bn. Funded exposure related to ECLGS was ~Rs144bn of which the SMA-1/2 further reduced QoQ from 2.9% to 1.5%. Restructured pool at Rs22bn or 5.3% of loans was stable QoQ with a PCR of 10%. Of this pool, 60% (Rs13bn) has become due (30% last quarter). Of the remaining 40% that is not due, ~33% (Rs7.3bn) has started paying EMI in advance. Hence effectively ~7% (Rs1.5bn) of the OTR pool has not paid a single EMI (last quarter 11%). SMA-2 pool contracted QoQ from 2% to 1.4%.

Loan growth guidance for FY23 unchanged: Credit growth target of 10-15% for FY23 was maintained although non-gold might drive the incremental flow which could support margins. Higher liquidity was a drag on margins however, there are levers in place for NIM enhancement viz. (1) CUBK generally has a positive ALM mismatch in <1yr maturity bucket which is beneficial in a rising interest rate environment (2) 70% of the portfolio is EBLR linked which is higher to peers and 3) incremental credit flow towards higher yielding assets. We expect NIM to improve from 3.7% in FY22 to 3.8% in FY23.

Shares of City Union Bank Limited was last trading in BSE at Rs. 130.45 as compared to the previous close of Rs. 134.10. The total number of shares traded during the day was 32787 in over 990 trades.

The stock hit an intraday high of Rs. 136.05 and intraday low of 129.90. The net turnover during the day was Rs. 4364144.00.

Click here to send ur comments or to

Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only., its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.

Other Headlines:

Gladiator Stocks - Minda Industries - ICICI Direct

Reliance Industries - Company Update - In fine fettle amidst global uncertainty - BUY

Sector Update - Sugar - ICICI Direct

Initiating Coverage - Hindustan Aeronautics Ltd - ICICI Direct

Rallis India - Company Update - Margin pressure likely to persist in near term..!! - Upgrade to 'BUY'

Indoco Remedies - Q4FY22 Result Update - In-line quarter; strong revenue guidance for US & EU mkt - Upgrade to 'BUY'

Indraprastha Gas - Q4FY22 Result Update - Impressive performance - BUY

KEC International - Annual Report Analysis - Healthy outlook across business segment - Accumulate

Westlife Development - Q4FY22 Result Update - Approaching the tipping point; Buy for LT Gains

Reliance Research downgrades Bajaj Auto to Sell

NOCIL - Q4FY22 Result Update - Strong operating performance amidst challenges - BUY

Gujarat Gas - Company Update - Deftly negotiating through tough times - BUY

Orient Electric - Gaining market share via innovation: initiate with ADD - ICICI Securities

Manappuram Finance - Q4FY22 Result Update - Intense Competition Put Pressure on Yields - BUY

Derivatives Weekly View - June 24, 2022 - ICICI Direct

Stock Tales - Newgen Software - ICICI Direct

Weekly Report - June 25, 2022 - Mr. Mitul Shah - Head of Research at Reliance securities

Gladiator Stocks - Bosch - ICICI Direct

Management Meet Update - Sheela Foam - ICICI Direct

Gladiator Stocks - Mahindra & Mahindra - ICICI Direct

Banks - Modifications to PPI and its impact on cards - Negligible impact, if any, for stocks under coverage

LIC Housing Finance - Q4FY22 Result Update - Fixed rate liabilities could cushion NIM - BUY

Navneet Education - Q4FY22 Result Update - Growth levers in place - BUY

MPC Minutes: Jun-22: All eyes on inflation - Acuité Ratings

Nazara Technologies - Management Meet Update - Breaking through the ESports landscape - BUY

Sector update - Quick Service Restaurants - YES Securities

JK Lakshmi Cement - Q4FY22 Result Update - Strong performance; Valuations drive upgrade - Accumulate

Would it be wise to invest in a home early in your career?

Dr. Reddy's Laboratories - Analyst Meet Update - Multiple growth initiatives - BUY

Dhanuka Agritech - Management Meet Update - 1Q likely to be subdued; all hopes pinned on the monsoons - BUY

BUY Ipca Laboratories - Q4FY22 Result Update - Weak exports; gradual recovery

Acuité expects India's current account deficit to widen to more than USD 90 bn in FY23 - Acuité Macro Pulse

Inflationary concerns will continue to weigh on the pace of economic revival in FY23 - Acuité Macroeconomic Performance index

Banks - BNPL - Early results are not that exciting as yet - Kotak

Acuité expects FY23 GDP growth estimate at 7.5% - Acuité Macro Pulse - Growth - May-22 Edition

Base factor pushes up IIP in Apr-22 to an 8-month high - Acuité Ratings

India Strategy & Q4FY22 Review - Long term growth prospects to overshadow near term uncertainties

India Equity Strategy - Quarterly flipbook: Q4FY22-Cost inflation driving downgrades

FMCG - D2C is here to stay; omni-channel the way forward - HDFC Securities

Automobile Sector - Monthly Quick View - May'22 - Steady Performance Improvement, backed by Gradual Rural Recovery

BFSI - New normal rate cycle; brace for transmission effects - HDFC Securities

SBI Cards and Payment Services - BUY - TP Rs. 1260 - YES SECURITIES

RBI frontloads rate hike amid increased inflationary headwinds - Acuité Ratings

Monetary Policy June 2022 - Axis MF Views

RBI Monetary Policy View - Mr. Dhiraj Relli, MD & CEO, HDFC Securities

Monetary Policy - entering the red zone - Anuj Puri, ANAROCK

Mr. Murali Ramakrishnan, MD &CEO, South Indian Bank on RBI Monetary Policy

Comments on RBI's MPC Policy Jun'22 - Acuité Ratings

Views on RBI Monetary Policy - June 2022

Bayer Cropscience - Q4FY22 Result Update - Healthy all round performance - BUY

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020